CompletedPhase 1

Intravitreal Bevacizumab in Agioid Streaks

Italy5 participantsStarted 2006-11

Plain-language summary

The purpose of this study is to investigate the safety and efficacy of intravitreal bevacizumab in patients with choroidal neovascularization associated with angioid streaks.

Who can participate

Age range44 Years – 67 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * presence of an active CNV * visual loss * increased retinal thickness Exclusion Criteria: * no actively leaking CNV by FAG * normal retinal thickness * satisfactory visual acuity

What they're measuring

BCVA improvement

Timeframe: 6 months

Trial details

NCT IDNCT00406250

SponsorUniversity of Campania Luigi Vanvitelli

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2008-12

View on ClinicalTrials.gov More Angioid Streaks trials